1. Home
  2. APEI vs MNKD Comparison

APEI vs MNKD Comparison

Compare APEI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APEI

American Public Education Inc.

HOLD

Current Price

$51.70

Market Cap

1.1B

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.33

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APEI
MNKD
Founded
1991
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
877.0M
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
APEI
MNKD
Price
$51.70
$3.33
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$52.14
$8.69
AVG Volume (30 Days)
230.8K
6.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
147.27
N/A
EPS
0.94
N/A
Revenue
$198,174,000.00
$348,966,000.00
Revenue This Year
$8.47
$35.81
Revenue Next Year
$7.00
$11.89
P/E Ratio
$54.88
N/A
Revenue Growth
N/A
22.23
52 Week Low
$25.81
$2.23
52 Week High
$61.59
$6.51

Technical Indicators

Market Signals
Indicator
APEI
MNKD
Relative Strength Index (RSI) 37.51 59.70
Support Level $50.04 $2.45
Resistance Level $59.73 $6.08
Average True Range (ATR) 2.48 0.26
MACD -0.50 0.01
Stochastic Oscillator 17.60 34.25

Price Performance

Historical Comparison
APEI
MNKD

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator, provides online postsecondary education as a distance-learning, graduate-level institution for military officers seeking a degree in military studies; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: